gammaCore
The gammaCore® therapy is the first of its kind: a non-invasive vagus nerve stimulator (nVNS) that uses proprietary electrical signals to treat primary headache, including Migraine, Cluster Headache, and Medication Overuse Headache (MOH).
-
-
electroCore’s Mission
electroCore‘s mission is to lead the world of NeuroScience by developing therapies that directly, and non-invasively, target nerve signal imbalances and restore normal neurological function to help patients live life to its fullest. -
Patient Testimonials
gammaCore® users share their experiences. -
Contact Us!
electroCore wants to hear from you! Navigate to our Contact section for general questions, investor-related topics, media inquiries, and much more.
-
Poster Presentation: Neuromodulation as Treatment …
In a poster presented at the CONy[1] meeting in Istanbul, by Dr. Alan Rapoport of the David Geffen School of Medicine at UCLA, the rapidly advancing field of neuromodulation was … -
electroCore Raises $40 Million to…
Participants in the round of financing include Merck GHI, Easton Capital, and CORE Ventures II. Morris Plains, NJ – April 9, 2013 – electroCore®, a company developing non-i… -
Data on electroCore’s Vagal Ner…
Results show gammaCore to be an effective, well-tolerated treatment for acute treatment of episodic migraine MORRIS PLAINS, NJ – March 13, 2013 – electroCore®, a compan… -
electroCore Receives Australian a…
gammaCore approved to treat primary headache in both countries Device now available in Australia via electroCore Australia with physician authorization MORRIS PLAINS, NJ …